Kazia Therapeutics
Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, I
Catapult Group International
Top broker says this ASX 200 tech stock is a buy with 30% upside
DroneShield
Morgans thinks this ASX healthcare stock could double!
Integral Diagnostics
Praemium
Capitol Health
2 ASX small-cap shares to buy right now
Mortgage Choice
BHP is a great company, but I think this ASX 200 stock is a better investment
Sigma Healthcare
At a multi-year low, is this ASX 200 healthcare share now a buy?
Emerald Resources
Explorers Podcast: Unity Metals sets sights on Southeast Asia’s untapped riches
Webster
Neuren Pharmaceuticals
Dimerix
Race Oncology
Global Health
The art of the health deal: How strong data opens doors
5 things to watch on the ASX 200 on Wednesday
Garda Capital Group
Renascor Resources
Why Aussie graphite projects are beginning to turn investors’ heads